List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global External Neuromodulation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Transcutaneous Electrical Nerve Stimulation
1.2.3 Transcranial Magnetic Stimulation
1.2.4 Respiratory Electrical Stimulation
1.3 Market by Application
1.3.1 Global External Neuromodulation Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global External Neuromodulation Market Perspective (2017-2028)
2.2 External Neuromodulation Growth Trends by Region
2.2.1 External Neuromodulation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 External Neuromodulation Historic Market Size by Region (2017-2022)
2.2.3 External Neuromodulation Forecasted Market Size by Region (2023-2028)
2.3 External Neuromodulation Market Dynamics
2.3.1 External Neuromodulation Industry Trends
2.3.2 External Neuromodulation Market Drivers
2.3.3 External Neuromodulation Market Challenges
2.3.4 External Neuromodulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top External Neuromodulation Players by Revenue
3.1.1 Global Top External Neuromodulation Players by Revenue (2017-2022)
3.1.2 Global External Neuromodulation Revenue Market Share by Players (2017-2022)
3.2 Global External Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by External Neuromodulation Revenue
3.4 Global External Neuromodulation Market Concentration Ratio
3.4.1 Global External Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by External Neuromodulation Revenue in 2021
3.5 External Neuromodulation Key Players Head office and Area Served
3.6 Key Players External Neuromodulation Product Solution and Service
3.7 Date of Enter into External Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 External Neuromodulation Breakdown Data by Type
4.1 Global External Neuromodulation Historic Market Size by Type (2017-2022)
4.2 Global External Neuromodulation Forecasted Market Size by Type (2023-2028)
5 External Neuromodulation Breakdown Data by Application
5.1 Global External Neuromodulation Historic Market Size by Application (2017-2022)
5.2 Global External Neuromodulation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America External Neuromodulation Market Size (2017-2028)
6.2 North America External Neuromodulation Market Size by Country (2017-2022)
6.3 North America External Neuromodulation Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe External Neuromodulation Market Size (2017-2028)
7.2 Europe External Neuromodulation Market Size by Country (2017-2022)
7.3 Europe External Neuromodulation Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific External Neuromodulation Market Size (2017-2028)
8.2 Asia-Pacific External Neuromodulation Market Size by Country (2017-2022)
8.3 Asia-Pacific External Neuromodulation Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America External Neuromodulation Market Size (2017-2028)
9.2 Latin America External Neuromodulation Market Size by Country (2017-2022)
9.3 Latin America External Neuromodulation Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa External Neuromodulation Market Size (2017-2028)
10.2 Middle East & Africa External Neuromodulation Market Size by Country (2017-2022)
10.3 Middle East & Africa External Neuromodulation Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Medtronic, Inc. (US)
11.1.1 Medtronic, Inc. (US) Company Detail
11.1.2 Medtronic, Inc. (US) Business Overview
11.1.3 Medtronic, Inc. (US) External Neuromodulation Introduction
11.1.4 Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.1.5 Medtronic, Inc. (US) Recent Development
11.2 Boston Scientific Corporation (US)
11.2.1 Boston Scientific Corporation (US) Company Detail
11.2.2 Boston Scientific Corporation (US) Business Overview
11.2.3 Boston Scientific Corporation (US) External Neuromodulation Introduction
11.2.4 Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2017-2022)
11.2.5 Boston Scientific Corporation (US) Recent Development
11.3 St. Jude Medical, Inc. (US)
11.3.1 St. Jude Medical, Inc. (US) Company Detail
11.3.2 St. Jude Medical, Inc. (US) Business Overview
11.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Introduction
11.3.4 St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.3.5 St. Jude Medical, Inc. (US) Recent Development
11.4 Synapse Biomedical, Inc. (US)
11.4.1 Synapse Biomedical, Inc. (US) Company Detail
11.4.2 Synapse Biomedical, Inc. (US) Business Overview
11.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Introduction
11.4.4 Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.4.5 Synapse Biomedical, Inc. (US) Recent Development
11.5 Nevro Corporation (US)
11.5.1 Nevro Corporation (US) Company Detail
11.5.2 Nevro Corporation (US) Business Overview
11.5.3 Nevro Corporation (US) External Neuromodulation Introduction
11.5.4 Nevro Corporation (US) Revenue in External Neuromodulation Business (2017-2022)
11.5.5 Nevro Corporation (US) Recent Development
11.6 Neurosigma, Inc. (US)
11.6.1 Neurosigma, Inc. (US) Company Detail
11.6.2 Neurosigma, Inc. (US) Business Overview
11.6.3 Neurosigma, Inc. (US) External Neuromodulation Introduction
11.6.4 Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.6.5 Neurosigma, Inc. (US) Recent Development
11.7 Neuropace, Inc. (US)
11.7.1 Neuropace, Inc. (US) Company Detail
11.7.2 Neuropace, Inc. (US) Business Overview
11.7.3 Neuropace, Inc. (US) External Neuromodulation Introduction
11.7.4 Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.7.5 Neuropace, Inc. (US) Recent Development
11.8 Neuronetics, Inc. (US)
11.8.1 Neuronetics, Inc. (US) Company Detail
11.8.2 Neuronetics, Inc. (US) Business Overview
11.8.3 Neuronetics, Inc. (US) External Neuromodulation Introduction
11.8.4 Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.8.5 Neuronetics, Inc. (US) Recent Development
11.9 Cyberonics, Inc. (US)
11.9.1 Cyberonics, Inc. (US) Company Detail
11.9.2 Cyberonics, Inc. (US) Business Overview
11.9.3 Cyberonics, Inc. (US) External Neuromodulation Introduction
11.9.4 Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2017-2022)
11.9.5 Cyberonics, Inc. (US) Recent Development
11.10 BioControl Medical (Israel)
11.10.1 BioControl Medical (Israel) Company Detail
11.10.2 BioControl Medical (Israel) Business Overview
11.10.3 BioControl Medical (Israel) External Neuromodulation Introduction
11.10.4 BioControl Medical (Israel) Revenue in External Neuromodulation Business (2017-2022)
11.10.5 BioControl Medical (Israel) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
